Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of Effect of Formulated Methylene Blue on Treatment of Squamous Cell Carcinoma Skin Cancer in Inoperable Patients and Not Suitable for Radiotherapy

NCT07311057 is registered in ClinicalTrials.gov with Daryoush Hamidi Alamdari, PhD as lead sponsor.

NCT NCT07311057
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07311057 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of Effect of Formulated Methylene Blue on Treatment of Squamous Cell Carcinoma Skin Cancer in Inoperable Patients and Not Suitable for Radiotherapy
Lead sponsor
Daryoush Hamidi Alamdari, PhD
Phase
Phase 3
Overall status
Enrolling by invitation
Start date
December 20, 2025
Completion date
January 20, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inoperable disease, scc - squamous cell carcinoma, scc - squamous cell carcinoma of skin